BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30535801)

  • 1. Variations on classification of main types of myocardial infarction: a systematic review and outcome meta-analysis.
    Vargas KG; Haller PM; Jäger B; Tscharre M; Binder RK; Mueller C; Lindahl B; Huber K
    Clin Res Cardiol; 2019 Jul; 108(7):749-762. PubMed ID: 30535801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic features, management and prognosis of type 2 myocardial infarction compared to type 1 myocardial infarction: a systematic review and meta-analysis.
    White K; Kinarivala M; Scott I
    BMJ Open; 2022 Feb; 12(2):e055755. PubMed ID: 35177458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, Trends, and Outcomes of Type 2 Myocardial Infarction in a Community Cohort.
    Raphael CE; Roger VL; Sandoval Y; Singh M; Bell M; Lerman A; Rihal CS; Gersh BJ; Lewis B; Lennon RJ; Jaffe AS; Gulati R
    Circulation; 2020 Feb; 141(6):454-463. PubMed ID: 31902228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type 2 myocardial infarction: A descriptive analysis and comparison with type 1 myocardial infarction.
    Landes U; Bental T; Orvin K; Vaknin-Assa H; Rechavia E; Iakobishvili Z; Lev E; Assali A; Kornowski R
    J Cardiol; 2016 Jan; 67(1):51-6. PubMed ID: 25956551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and occurrence of type 2 myocardial infarction in emergency department patients: a prospective study.
    Greenslade JH; Adikari T; Mueller C; Sandoval Y; Nestelberger T; Parsonage W; Hawkins T; Cullen L
    Emerg Med J; 2018 Mar; 35(3):169-175. PubMed ID: 28784608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 2 myocardial infarction: incidence, presentation, treatment and outcome in routine clinical practice.
    Radovanovic D; Pilgrim T; Seifert B; Urban P; Pedrazzini G; Erne P
    J Cardiovasc Med (Hagerstown); 2017 May; 18(5):341-347. PubMed ID: 28107211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of objective evidence of myocardial ischemia to facilitate the diagnostic and prognostic distinction between type 2 myocardial infarction and myocardial injury.
    Sandoval Y; Smith SW; Sexter A; Schulz K; Apple FS
    Eur Heart J Acute Cardiovasc Care; 2020 Feb; 9(1):62-69. PubMed ID: 29979092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality following myocardial infarction among HIV-infected persons: the Center for AIDS Research Network Of Integrated Clinical Systems (CNICS).
    Feinstein MJ; Nance RM; Delaney JAC; Heckbert SR; Budoff MJ; Drozd DR; Burkholder GA; Willig JH; Mugavero MJ; Mathews WC; Moore RD; Eron JJ; Napravnik S; Hunt PW; Geng E; Hsue P; Peter I; Lober WB; Crothers K; Grunfeld C; Saag MS; Kitahata MM; Lloyd-Jones DM; Crane HM
    BMC Med; 2019 Jul; 17(1):149. PubMed ID: 31362721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification Algorithm to Distinguish Between Type 1 and Type 2 Myocardial Infarction in Administrative Claims Data.
    Wasfy JH; Price M; Normand ST; Januzzi JL; McCarthy CP; Hsu J
    Circ Cardiovasc Qual Outcomes; 2024 Feb; 17(2):e009986. PubMed ID: 38240159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-month cardiovascular prognostic impact of type 1 And type 2 myocardial infarction in patients hospitalized for gastrointestinal bleeding.
    Pemmasani G; Ashwath A; Aronow WS; Yandrapalli S; Leighton J; John S
    Eur J Intern Med; 2023 Oct; 116():51-57. PubMed ID: 37500309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Twelve-Month Outcomes of Patients With Myocardial Injury not Due to Type-1 Myocardial Infarction.
    Rocheleau S; Eng-Frost J; Lambrakis K; Khan E; Chiang B; Wattchow N; Steele S; Lorensini S; Lehman SJ; Papendick C; Chew DP
    Heart Lung Circ; 2023 Aug; 32(8):978-985. PubMed ID: 37225600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discordance between ICD-Coded Myocardial Infarction and Diagnosis according to the Universal Definition of Myocardial Infarction.
    Díaz-Garzón J; Sandoval Y; Smith SW; Love S; Schulz K; Thordsen SE; Johnson BK; Driver B; Jacoby K; Carlson MD; Dodd KW; Moore J; Scott NL; Bruen CA; Hatch R; Apple FS
    Clin Chem; 2017 Jan; 63(1):415-419. PubMed ID: 27811209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of outcome among type 2 vs type 1 myocardial infarction: a systematic review and meta-analysis.
    Jaiswal V; Ang SP; Ishak A; Nasir YM; Chia JE; Naz S; Jaiswal A
    J Investig Med; 2023 Mar; 71(3):223-234. PubMed ID: 36705027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction.
    Horiuchi Y; Wettersten N; Patel MP; Mueller C; Neath SX; Christenson RH; Morgenthaler NG; McCord J; Nowak RM; Vilke GM; Daniels LB; Hollander JE; Apple FS; Cannon CM; Nagurney JT; Schreiber D; deFilippi C; Hogan C; Diercks DB; Headden G; Limkakeng AT; Anand I; Wu AHB; Ebmeyer S; Jaffe AS; Peacock WF; Maisel A
    Circulation; 2020 Oct; 142(16):1532-1544. PubMed ID: 32820656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic impact of new pathophysiology-based categorization of type 1 and type 2 myocardial infarction: data from the French RICO survey.
    Yao H; Cottin Y; Chagué F; Maza M; Bichat F; Zeller M; Putot A
    Am Heart J; 2023 Dec; 266():86-97. PubMed ID: 37703947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid-related protein 8/14 and high-sensitivity cardiac troponin I to differentiate type 2 myocardial infarction.
    Bormann J; Psyrakis DA; von Jeinsen B; Grün D; Elsner LK; Wolter JS; Weferling M; Diouf K; Kriechbaum S; Troidl C; Dörr O; Nef H; Hamm CW; Liebetrau C; Keller T
    Int J Cardiol; 2020 Apr; 304():144-147. PubMed ID: 32008845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis Comparing Outcomes of Type 2 Myocardial Infarction and Type 1 Myocardial Infarction With a Focus on Dual Antiplatelet Therapy.
    Reid C; Alturki A; Yan A; So D; Ko D; Tanguay JF; Bessissow A; Mehta S; Goodman S; Huynh T
    CJC Open; 2020 May; 2(3):118-128. PubMed ID: 32462125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordance and Prognostic Relevance of Angiographic and Clinical Definitions of Myocardial Infarction Type.
    Hoang TH; Lazarev PV; Maiskov VV; Merai IA; Kobalava ZD
    J Cardiovasc Pharmacol Ther; 2021 Sep; 26(5):463-472. PubMed ID: 33836638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudo-targeted metabolic profile differences between emergency patients with type 1 and type 2 myocardial infarction diagnosed by optical coherence tomography.
    Wang J; Li Z; Yang G; Fang C; Yin Y; Zheng Z; Wang H; Fang S; Dai J; Wang S; Yang S; Yu B
    Clin Chim Acta; 2024 Feb; 554():117745. PubMed ID: 38185283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of type 1 and type 2 myocardial infarction using a high-sensitivity cardiac troponin I assay with sex-specific 99th percentiles based on the third universal definition of myocardial infarction classification system.
    Sandoval Y; Smith SW; Schulz KM; Murakami MM; Love SA; Nicholson J; Apple FS
    Clin Chem; 2015 Apr; 61(4):657-63. PubMed ID: 25672334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.